Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AUSSIE BROADBAND LIMITED Director's Dealing 2025

Jan 15, 2025

64278_rns_2025-01-15_c8373c6d-4f05-45b8-bd67-896aace9641b.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity: Aussie Broadband Limited

ABN: 29 132 090 192

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Michael Omeros
Date of last notice 14 November 2024

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct/Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Michael Omeros as trustee for the Milimais
Investment Trust
Linda Kaye Omeros (Spouse) as trustee for
Isabella Ann Omeros (Daughter)
Linda Kaye Omeros (Spouse) as trustee for
Madeline Omeros (Daughter)
Omeros Superannuation Pty Ltd Family Super Fund>
Date of change 15 January 2025
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change Michael Omeros: 415,181 Ordinary Shares,
163,597 Options under LTIP
Michael Omeros as trustee for the Milimais
Investment Trust: 4,220,479
Linda Kaye Omeros (Spouse) as trustee for
Isabella Ann Omeros: 5,000
Linda Kaye Omeros (Spouse) as trustee for
Madeline Omeros: 5,000
Omeros Superannuation Pty Ltd Family Super Fund>: 25,222
Class Unquoted Options issued under the LTI Plan,
expiring 15-Jan-2031.
Number acquired 135,150
Number disposed Nil
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
Exercise price of $3.52 per option
No. of securities held after change Michael Omeros: 415,181 Ordinary Shares,
298,747 Options under LTIP
Michael Omeros as trustee for the Milimais
Investment Trust: 4,220,479
Linda Kaye Omeros (Spouse) as trustee for
Isabella Ann Omeros: 5,000
Linda Kaye Omeros (Spouse) as trustee for
Madeline Omeros: 5,000
Omeros Superannuation Pty Ltd Family Super Fund>: 25,222
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue
of securities under dividend reinvestment plan, participation in buy-
back
Issue of Options under the LTI Plan as
previously approved by shareholders at the
Annual General Meeting held on 25 October
2024.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Name of registered holder
(if issued securities)
N/A
Date of change N/A
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in
relation to which the interest has changed
N/A
Interest acquired N/A
Interest disposed N/A
Value/Consideration
Note: If consideration is non-cash, provide details
and an estimated valuation
N/A
Interest after change N/A

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed
above traded during a+closed period where prior
written clearance was required?
The Company’s trading window
is currently closed, however the
Options
are
unquoted
securities issued in accordance
with
shareholder
approval
granted
at
the
Company’s
Annual General Meeting on 25
October 2024. As noted in the
Explanatory
Memorandum
contained in the Notice of
Annual General Meeting, the
Options are required to be
issued within 3 months of
receiving shareholder approval.
If so, was prior written clearance provided to allow the
trade to proceed during this period?
N/A
If prior written clearance was provided, on what date
was this provided?
N/A
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3